NEA funds forward thinking basic, clinical and translational adult and pediatric eczema research guided by the five research priorities established by our Scientific & Medical Advisory Council:
- Cutting-Edge Basic & Translational Science
Innovative investigations of targets, pathways or technologies that will advance understanding of the pathophysiology or natural history of eczema, and potentially lead to novel or enhanced therapeutic/preventative areas of exploration or application.
- Eczema Heterogeneity: Novel Insights
Projects aimed at advancing understanding of the underlying factors contributing to the diversity of eczema clinical presentation, treatment response and comorbidities.
- Innovations in Clinical Practice & Care
Studies addressing approaches to facilitate optimal identification and treatment of eczema and associated comorbidities in all health care settings to enhance patient-reported and patient-centric outcomes.
- Understanding & Alleviating Disease Burden
Insightful proposals that identify, quantify or aim to reduce aspects of eczema burden that negatively affect patient or family/caregiver quality of life (including lifestyle, academic/occupational, or economic impacts) based on patient population, treatment approach, etc.
- Eczema Prevention
Novel investigations into the potential risk factors and strategies of primary eczema prevention at all ages.